Kisoji Biotechnology

Home - Kisoji Biotechnology Inc.

Montreal, United States · $41.0M raised

Headquarters
Montreal
Business Model
B2B
Total Funding
$41.0M
Last Round
$41.0M Series BDec 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

KisoJi Biotechnology is a Montreal-based, next-generation antibody company that discovers and develops highly differentiated antibody therapeutics for oncology and other difficult-to-treat diseases. Its proprietary platform uses multi-species single-domain antibody transgenic mice, AI-enabled antibody fingerprinting, and a toolkit for building robust, manufacturable multi-specific antibodies, giving researchers direct control over antibody sampling for therapeutic, diagnostic, and vaccine development. The company's lead candidate, KJ-103, is a first-in-class 'naked' anti-TROP2 antibody now in IND-enabling studies, designed to combine potency and specificity without the toxicities associated with antibody-drug conjugates.

Summary

Kisoji Biotechnology is a Biotech company based in Montreal, United States. It has raised $41.0M in total across 1 round, most recently a $41.0M Series B round in Dec 2024. Investors include Lumira Ventures and Investissement Québec.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BDec 2024
$41.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kisoji Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/kisoji-biotechnology"><img src="https://indexed.vc/api/badge/company/kisoji-biotechnology" alt="Kisoji Biotechnology on Indexed.vc" width="260" height="76" /></a>